We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Wyeth on Wednesday faced accusations that one of its hormone replacement therapy (HRT) drugs caused breast cancer in a 67-year-old woman as one of the thousands of trials the drug maker is facing over the treatment got under way.
A U.S. District Court judge has opened the door for generic drug companies to market competing versions of Wellbutrin, a popular antidepressant drug, made by Biovail Corp.
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced that it has reached a settlement with Unimed Pharmaceuticals, Inc., a wholly owned subsidiary of Solvay Pharmaceuticals, Inc., and Laboratories Besins Iscovesco on outstanding patent litigation related to AndroGel 1% (testosterone gel) CIII, a topical testosterone replacement gel.
Actavis Group, the international generic pharmaceuticals company, announced that it has received a warning letter from the U.S. Food and Drug Administration (FDA), related to its inspection of the Group's solid oral dose manufacturing facility in Little Falls, New Jersey.
The Greek antitrust regulatory agency has dismissed a complaint filed against GlaxoSmithKline (GSK) by a group of pharmacists, wholesalers and distributors claiming the company improperly restrained trade in that country.
California's proposed prescription drug program wrongly imposes artificial price controls that could undermine future innovations, the drug industry says.
Stanford University's Medical Center is joining a number of other academic institutions in prohibiting its physicians and researchers from accepting gifts of any kind in an effort to prevent conflicts of interest.